Some biotech investors had probably never heard of exosomes until Codiak’s chief executive, Doug Williams, made his pitch at the JP Morgan conference two weeks ago. But the area has been gaining traction, and Jazz’s $56m up-front...
Read More »Evox Therapeutics to Collaborate with Boehringer Ingelheim on Exosome-Mediated Drug Delivery
Evox Therapeutics Ltd, a leading exosome therapeutics company, today announces that it has entered into a research collaboration with Boehringer
Read More »Summer Intern Position Available – Biomarker Discovery
Description: Boehringer Ingelheim is currently seeking a talented and innovative **Intern** to join our CardioMetabolic Diseases Research department located at our Ridgefield, CT facility. As an Intern, you will work with animal and human samples to identify and validate novel ...
Read More »